Zenas Biopharma
ZBIO----
全部股東
股東類型
- 機構投資者75.36%
- 上市公司12.35%
- 創投/私募11.08%
- 個人與內幕人士1.21%
- 私人企業0.00%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
FMR LLC | 14.59% | 950.67 萬 | 0.03% | +42.47 萬 | 30/06/2026 |
InnoCare Pharma Limited | 10.74% | 700.00 萬 | 2.84% | +200.00 萬 | 31/08/2026 |
Wellington Management Group LLP | 10.07% | 656.61 萬 | 7.56% | +497.23 萬 | 31/08/2026 |
SR One Capital Management, LP | 7.73% | 503.79 萬 | 0.23% | +0 | 13/08/2026 |
New Enterprise Associates, Inc. | 6.17% | 402.32 萬 | 0.28% | +0 | 30/06/2026 |
Zebra Aggregator, LP | 4.98% | 324.54 萬 | -- | +324.54 萬 | 19/08/2026 |
Federated Hermes, Inc. | 4.78% | 311.68 萬 | 0.23% | -1.02 萬 | 30/06/2026 |
Xencor, Inc. | 4.75% | 309.84 萬 | 0.21% | +0 | |
BlackRock, Inc. | 4.12% | 268.62 萬 | 0.86% | +64.87 萬 | 30/06/2026 |
Longitude Capital Management Co., LLC | 4.00% | 260.72 萬 | 0.18% | +0 | |
Capital Research and Management Company | 3.84% | 250.29 萬 | 0.06% | +6.89 萬 | 30/06/2026 |
Polar Capital Holdings Plc | 3.70% | 241.28 萬 | 0.38% | -13.57 萬 | 30/06/2026 |
RP Management, LLC | 3.66% | 238.82 萬 | 0.16% | +0 | 30/06/2026 |
Fairmount Funds Management LLC | 3.62% | 235.90 萬 | 0.16% | +0 | 30/06/2026 |
State Street Investment Management | 3.15% | 205.51 萬 | 0.80% | +58.42 萬 | 30/06/2026 |
NVP Associates, LLC | 2.82% | 183.85 萬 | 0.13% | +0 | 30/06/2026 |
Tellus BioVentures, LLC | 2.74% | 178.60 萬 | 0.03% | +6.00 萬 | 18/05/2026 |
Vanguard Capital Management, LLC | 2.47% | 160.95 萬 | 0.19% | +18.47 萬 | 30/06/2026 |
Bank of America Corporation | 1.89% | 123.12 萬 | 1.27% | +84.28 萬 | 30/06/2026 |
T. Rowe Price Group, Inc. | 1.88% | 122.69 萬 | 1.31% | +86.97 萬 | 30/06/2026 |